CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
On July 3, 2025, a U.S.-based biotechnology — the sole appellant among the original two opponents — formally withdrew its appeal against the EPO Opposition Division's earlier decision to maintain the patent. This withdrawal renders the EPO's decision final and binding for the opponents, effectively concluding their part in the opposition process.
The patent was granted by the EPO in 2022 and opposed by two parties in 2023. Following oral proceedings, the EPO Opposition Division issued a decision to maintain the patent in amended form, upholding key claims related to the use of GPC3 CAR-T cell therapy following cyclophosphamide and fludarabine lymphodepletion pretreatment, in the treatment of liver cancer, lung cancer, ovarian cancer, breast cancer, gastric cancer, and thyroid cancer. Following the decision, only one opponent filed an appeal within the allowable period. That appeal has now been withdrawn.
Under EPO procedures, the opponents or any other third party can no longer challenge the patent at the EPO. This development further reinforces CARsgen's intellectual property position in the field of GPC3-targeted CAR-T therapies, a promising and innovative approach for the treatment of solid tumors.
About CARsgen Therapeutics Holdings Limited
CARsgen is a biopharmaceutical company focusing on developing innovative CAR T-cell therapies to address the unmet clinical needs including but not limited to hematologic malignancies, solid tumors and autoimmune diseases. CARsgen has established end-to-end capabilities for CAR T-cell research and development covering target discovery, preclinical research, product clinical development, and commercial-scale production. CARsgen has developed novel in-house technologies and a product pipeline with global rights to address challenges faced by existing CAR T-cell therapies. Efforts include improving safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs, etc. CARsgen's mission is to be a global biopharmaceutical leader that provides innovative and differentiated cell therapies for patients worldwide and makes cancer and other diseases curable.
Forward-looking Statements
All statements in this press release that are not historical fact or that do not relate to present facts or current conditions are forward-looking statements. Such forward-looking statements express the Group's current views, projections, beliefs and expectations with respect to future events as of the date of this press release. Such forward-looking statements are based on a number of assumptions and factors beyond the Group's control. As a result, they are subject to significant risks and uncertainties, and actual events or results may differ materially from these forward-looking statements and the forward-looking events discussed in this press release might not occur. Such risks and uncertainties include, but are not limited to, those detailed under the heading 'Principal Risks and Uncertainties' in our most recent annual report and interim report and other announcements and reports made available on our corporate website, https://www.carsgen.com. No representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on, any projections, targets, estimates or forecasts contained in this press release.
Contact CARsgen
For more information, please visit https://www.carsgen.com/
View original content to download multimedia: https://www.prnewswire.com/news-releases/carsgen-successfully-defends-its-gpc3-car-t-patent-at-the-epo-302503880.html
SOURCE CARsgen Therapeutics
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
China expected to keep lending rates steady, focus turns to Politburo meet
SHANGHAI (Reuters) -China is widely expected to leave its benchmark lending rates unchanged at a monthly fixing on Monday, a Reuters survey showed, as signs of economic resilience reduced the urgency for further monetary easing. The loan prime rate (LPR), normally charged to banks' best clients, is calculated each month after 20 designated commercial banks submit proposed rates to the People's Bank of China (PBOC). In a Reuters survey of 20 market watchers conducted this week, all respondents expected both the one-year and five-year LPRs to remain steady. Most new and outstanding loans in China are based on the one-year LPR, while the five-year rate influences the pricing of mortgages. The consensus of no immediate monetary easing comes as data this week showed China's second-quarter gross domestic product (GDP) growth nudged slightly above market expectations, even though weak domestic demand and uncertainty around U.S. tariffs have raised economic risks. "Although continued downward price pressures and sluggish loan demand present a solid case for further easing, the PBOC may opt to hold off until a more opportune window," said Lynn Song, chief China economist for Greater China at ING. "We continue to expect one more 10-basis-point rate cut and 50-basis-point reserve requirement ratio (RRR) cut before year-end." For now, market attention would be squarely on the Politburo meeting later this month, which is likely to shape economic policy for the rest of the year, traders and analysts said. "With H1 real GDP growth still solid, we do not think policymakers see the immediate need to launch broad-based, significant stimulus in the near-term, including at the July Politburo meeting," analysts at Goldman Sachs said in a note. "Instead, we expect incremental, targeted easing to help stem the property downturn and mitigate labour market pressures in H2." China's new home prices declined at the fastest pace in eight months in June from the previous month, official data showed on Tuesday, underscoring the challenges policymakers face in reviving demand even after multiple rounds of support measures.
Yahoo
10 minutes ago
- Yahoo
Volvo AB (VLVLY) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth
Net Sales: SEK123 billion, a year-over-year decline of 12% and a 5% decline when adjusted for currency. Adjusted Operating Income: SEK13.5 billion with an operating margin of 11%. Cash Flow: SEK2.9 billion, resulting in a net cash position of SEK43.1 billion in industrial operations. Return on Capital Employed: 25.7% on a rolling 12-month basis. Earnings Per Share: SEK3.64. Truck Deliveries: Declined by 10% in the quarter. Construction Equipment Deliveries: Increased by 11%. Fully Electric Vehicle Orders: Increased by 59%. Truck Sales: Declined by 9% adjusted for currency. Construction Equipment Sales: Increased by 2% adjusted for currency. Volvo Penta Sales: Increased by 18% driven by handset engines in the Industrial segment. Service Business: SEK126 billion 12 months rolling, flat adjusted for currency. Operating Cash Flow: SEK2.9 billion, impacted by high level of investments and onetime items. Adjusted Operating Income Margin for Construction Equipment: 13.1%. Adjusted Operating Income for Buses: SEK474 million with a margin of 7.9%. Volvo Penta Adjusted Operating Margin: 20.7%, an all-time high for the second quarter. Financial Services Credit Portfolio: Increased by 5% to SEK264 billion. Warning! GuruFocus has detected 4 Warning Sign with VLVLY. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Volvo AB (VLVLY) achieved a solid adjusted operating margin of 11% despite market uncertainties. The company reported a strong cash flow of SEK2.9 billion, resulting in a net cash position of SEK43.1 billion in industrial operations. Volvo AB (VLVLY) saw a 59% increase in orders for fully electric vehicles, with significant growth in SDLG machines in China and truck orders. The launch of new models like Mack's Anthem and Volvo's VNL and VNR is expected to strengthen the company's market position. Volvo Autonomous Solutions reached a milestone by autonomously hauling over 1 million tonnes of limestone, showcasing the potential of autonomous technology. Negative Points Net sales declined by 12% year-over-year, primarily due to lower truck volumes. The societal shift to zero-emission solutions is slower than anticipated, leading to a SEK4.5 billion negative impact on operating income. Truck deliveries declined by 10% in the quarter, with significant drops in North and South America. The company faced under-absorption issues in North America due to a 'wait-and-see' attitude among customers. Tariff costs and material costs are expected to have a growing negative impact on financial results in the coming quarters. Q & A Highlights Q: Can you provide insights into the North American truck market, where your performance was better than the overall market? A: Martin Lundstedt, CEO, explained that Volvo is gaining market share in North America due to a strong product lineup and early adjustments to market conditions. The company has managed inventory levels well and is seeing improved market share for Mack Trucks as delivery issues are resolved. Q: What is Volvo's strategy for the truck business in China following the divestment of the SDLG brand? A: Martin Lundstedt stated that Volvo will focus on selected segments in China, emphasizing TCO-driven and lifecycle-driven solutions. The partnership with Dongfeng will continue to build robustness and resilience in the market. Q: How will tariffs impact Volvo's financials in the coming quarters? A: Mats Backman, CFO, noted that the impact of tariffs will gradually increase, but Volvo is working on compensating for these effects through pricing strategies. The net effect of tariffs is expected to be negative, but the company is managing the situation proactively. Q: Can you discuss the cash position and its implications for future dividends? A: Mats Backman highlighted that Volvo maintains a strong balance sheet to support innovation and shareholder returns. The cash position is influenced by strategic investments and currency effects, but the underlying cash flow remains solid. Q: What is the outlook for truck production in North America given the current market conditions? A: Martin Lundstedt mentioned that Volvo is adjusting production levels to align with market demand and maintain flexibility. The company is prepared to continue adjustments as necessary, focusing on maintaining commercial and price discipline. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
Yahoo
10 minutes ago
- Yahoo
Nordea Bank Abp (NRDBY) Q2 2025 Earnings Call Highlights: Strong ROE and Asset Growth Amidst ...
Return on Equity: 16.2%. Earnings Per Share: EUR0.35. Mortgage Lending Growth: 6% increase. Retail Deposits Growth: 8% increase. Corporate Lending and Deposits Growth: 5% increase year-on-year. Assets Under Management: 9% increase to EUR437 billion. Net Interest Income: Decreased by 6% year-on-year and 2% quarter-on-quarter. Operating Profit: EUR1.6 billion, stable quarter-on-quarter. Cost Increase: 3% excluding foreign exchange effects. Cost-to-Income Ratio: 46.1%. Net Loan Losses: Net reversal of EUR21 million. CET1 Ratio: 15.6%, 1.9 percentage points above regulatory requirement. Net Flows in Private Banking: EUR2 billion. Gross Written Premiums: EUR3 billion. Warning! GuruFocus has detected 4 Warning Sign with NRDBY. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Nordea Bank Abp (NRDBY) delivered a strong return on equity of 16.2% for Q2 2025, highlighting its structural improved profitability. Mortgage lending increased by 6% and retail deposits were up 8%, driven by strong performance in Norway and Sweden. Assets under management grew by 9% to EUR437 billion, demonstrating resilience in turbulent markets. The bank maintained a strong capital position with a CET1 ratio of 15.6%, which is 1.9 percentage points above the regulatory requirement. Nordea Bank Abp (NRDBY) continued significant investments in technology, digital capabilities, data and AI, and cybersecurity to support future growth and resilience. Negative Points Net interest income decreased by 6% year-on-year due to the declining interest rate environment. Operating profit was slightly down at EUR1.6 billion compared to EUR1.7 billion a year ago. Cost increased by 3% excluding foreign exchange effects, driven by strategic investments including the Norwegian acquisition. Net fee and commission income was stable year-on-year but impacted by financial market turmoil. The equity capital markets and mergers and acquisitions activities remained challenging with volatility and uncertainty postponing transactions. Q & A Highlights Q: You maintain your guidance of more than 15% ROE for the year and your cost guidance. Given the current rate environment, how do you see the outlook for the various P&L items for the remainder of the year? A: Ian Smith, CFO, explained that despite market volatility and lower activity levels, especially in equity and corporate finance, Nordea finished the first half strongly. The expectation is for a quieter Q3 due to usual seasonality and cautious customer behavior, but momentum is expected to build into Q4. Net interest income (NII) is expected to be lower but resilient, with some pressure on lending margins due to competition. Fee income is expected to slow in Q3, and net fair value is anticipated to be smaller in the second half. Cost guidance remains at 2% to 2.5% growth for the full year. Q: You reduced your management judgment buffer by EUR60 million. Can we expect further reductions in H2? Also, how close can you realistically get to your 1.5% management buffer target? A: Ian Smith confirmed that Nordea expects to either use or release the management judgment buffer, with releases likely due to strong credit quality. On capital, Nordea maintains a substantial excess over the regulatory requirement and the 1.5% management buffer, providing flexibility for buybacks and capital distribution. Q: Regarding NII sensitivity to interest rate changes, how significant would the impact be if rates fall further in the Nordic countries? A: Ian Smith noted that Nordea's sensitivity range accounts for rate path uncertainties. While there is an expectation of a rate cut in Norway, the sensitivity remains towards the upper end of the range. In Norway, NII compression is due to internal factors rather than rate cuts, and in Denmark, competitive pressures are affecting margins. Q: Could you provide an update on the Norwegian business after the integration of the acquisition from Danske? A: Frank Vang-Jensen, CEO, stated that the integration is progressing well, with positive customer engagement and cross-selling opportunities. The business case is aligned with or slightly better than planned, with strong ancillary and cross-sell metrics in Norway compared to Sweden. Q: What are the main themes for the upcoming Capital Markets Day? A: Frank Vang-Jensen mentioned that the focus will be on building on Nordea's strong foundation, growing income above market rates, leveraging Nordic scale, and maintaining market-leading returns and superior EPS growth. The aim is to demonstrate how Nordea will achieve these goals. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
